BLADDER CANCER

BLADDER CANCER Journal

publication venue for

North American study and meta-analysis evaluating performance of Bladder EpiCheck®, a FDA cleared test, in non-muscle invasive bladder cancer recurrence. 10:278-289. 2024
Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer. 10:199-213. 2024
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer. 4:293-301. 2018
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer. 4:293-301. 2018

International Standard Serial Number (ISSN)

2352-3727

Electronic International Standard Serial Number (EISSN)

2352-3735

journal abbreviation

BLADDER CANCER